News searcher
ROVI achieves an increase of 29% in operating income and 74% in EBITDA
ROVI achieves an increase of 29% in operating income and 74% in EBITDA
ROVI reports first quarter 2021 financial results
6 min
13 May, 2021
ROVI increases its fill-finish capacity for the COVID-19 Vaccine Moderna
ROVI increases its fill-finish capacity for the COVID-19 Vaccine Moderna
ROVI invests in two new production lines at ROVI's facilities in San Sebastián de los Reyes (Madrid). These lines...
2 min
29 Apr, 2021
ROVI participates in the manufacture of the active substance of Moderna’s COVID-19 vaccine
Investment in a new production line at ROVI's Granada facility, which will lead to greater vertical integration in...
2 min
12 Apr, 2021
ROVI achieves a 10% increase in operating income and 55% in net profit
ROVI achieves a 10% increase in operating income and 55% in net profit
Summary of financial results achieved in 2020
5 min
24 Feb, 2021
Full Year 2020 Results Press Release
Download our press release published on 24 February to find out the financial results for 2020.
0 min
24 Feb, 2021
ROVI completes the manufacture of the first batches of Moderna vaccine
Laboratorios Farmacéuticos Rovi, S.A. (BME -Spanish Stock Exchanges and Markets: ROVI), a pan-European specialised...
0 min
13 Jan, 2021
ROVI completes the manufacture of the first batches of Moderna vaccine for EU
First batches of the Moderna's vaccine against COVID-19
2 min
13 Jan, 2021
The Journal npj Schizophrenia Publishes the Results of the PRISMA-3 Study of the Efficacy...
The results of the phase III pivotal clinical trial show that the once-monthly injectable antipsychotic Doria®...
4 min
27 Nov, 2020
The Spanish Prime Minister, Pedro Sánchez, makes an institutional visit to ROVI’s facility in San Sebastián de los Reyes (Madrid)
The Spanish Prime Minister, Pedro Sánchez, makes an institutional visit to ROVI’s...
During the visit, he was accompanied by the Minister of Science and Innovation, Pedro Duque, and the Director of the...
3 min
26 Nov, 2020